nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalidixic Acid—SLC22A6—Stavudine—acquired immunodeficiency syndrome	0.311	0.406	CbGbCtD
Nalidixic Acid—SLC22A6—Didanosine—acquired immunodeficiency syndrome	0.236	0.308	CbGbCtD
Nalidixic Acid—SLC22A6—Zidovudine—acquired immunodeficiency syndrome	0.124	0.162	CbGbCtD
Nalidixic Acid—SLC22A6—Lamivudine—acquired immunodeficiency syndrome	0.0958	0.125	CbGbCtD
Nalidixic Acid—TDO2—lung—acquired immunodeficiency syndrome	0.00214	0.222	CbGeAlD
Nalidixic Acid—TDO2—nervous system—acquired immunodeficiency syndrome	0.00198	0.205	CbGeAlD
Nalidixic Acid—TDO2—central nervous system—acquired immunodeficiency syndrome	0.00191	0.198	CbGeAlD
Nalidixic Acid—TDO2—brain—acquired immunodeficiency syndrome	0.00151	0.157	CbGeAlD
Nalidixic Acid—TDO2—lymph node—acquired immunodeficiency syndrome	0.00146	0.152	CbGeAlD
Nalidixic Acid—Convulsion—Abacavir—acquired immunodeficiency syndrome	0.000764	0.00342	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Saquinavir—acquired immunodeficiency syndrome	0.000763	0.00341	CcSEcCtD
Nalidixic Acid—Arthralgia—Stavudine—acquired immunodeficiency syndrome	0.000762	0.00341	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Ritonavir—acquired immunodeficiency syndrome	0.000759	0.00339	CcSEcCtD
Nalidixic Acid—Visual impairment—Efavirenz—acquired immunodeficiency syndrome	0.000757	0.00339	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Nevirapine—acquired immunodeficiency syndrome	0.000757	0.00339	CcSEcCtD
Nalidixic Acid—Paraesthesia—Didanosine—acquired immunodeficiency syndrome	0.000755	0.00338	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Amprenavir—acquired immunodeficiency syndrome	0.000755	0.00338	CcSEcCtD
Nalidixic Acid—Arthralgia—Abacavir—acquired immunodeficiency syndrome	0.000751	0.00336	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Efavirenz—acquired immunodeficiency syndrome	0.000742	0.00332	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Nevirapine—acquired immunodeficiency syndrome	0.000741	0.00331	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Saquinavir—acquired immunodeficiency syndrome	0.000738	0.0033	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Saquinavir—acquired immunodeficiency syndrome	0.00073	0.00327	CcSEcCtD
Nalidixic Acid—Abdominal pain—Amprenavir—acquired immunodeficiency syndrome	0.00073	0.00326	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Abacavir—acquired immunodeficiency syndrome	0.00072	0.00322	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Nelfinavir—acquired immunodeficiency syndrome	0.000717	0.00321	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Stavudine—acquired immunodeficiency syndrome	0.000715	0.0032	CcSEcCtD
Nalidixic Acid—Angioedema—Zidovudine—acquired immunodeficiency syndrome	0.000711	0.00318	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Delavirdine—acquired immunodeficiency syndrome	0.00071	0.00318	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Abacavir—acquired immunodeficiency syndrome	0.000705	0.00315	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Lamivudine—acquired immunodeficiency syndrome	0.000704	0.00315	CcSEcCtD
Nalidixic Acid—Vertigo—Zidovudine—acquired immunodeficiency syndrome	0.000699	0.00313	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Lamivudine—acquired immunodeficiency syndrome	0.000697	0.00312	CcSEcCtD
Nalidixic Acid—Leukopenia—Zidovudine—acquired immunodeficiency syndrome	0.000696	0.00312	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Nevirapine—acquired immunodeficiency syndrome	0.000689	0.00308	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Didanosine—acquired immunodeficiency syndrome	0.000688	0.00308	CcSEcCtD
Nalidixic Acid—Erythema—Efavirenz—acquired immunodeficiency syndrome	0.000684	0.00306	CcSEcCtD
Nalidixic Acid—Paraesthesia—Nevirapine—acquired immunodeficiency syndrome	0.000679	0.00304	CcSEcCtD
Nalidixic Acid—Convulsion—Zidovudine—acquired immunodeficiency syndrome	0.000674	0.00302	CcSEcCtD
Nalidixic Acid—Somnolence—Nevirapine—acquired immunodeficiency syndrome	0.000673	0.00301	CcSEcCtD
Nalidixic Acid—Visual impairment—Ritonavir—acquired immunodeficiency syndrome	0.00067	0.003	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.000668	0.00299	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Stavudine—acquired immunodeficiency syndrome	0.000665	0.00298	CcSEcCtD
Nalidixic Acid—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.000665	0.00298	CcSEcCtD
Nalidixic Acid—Arthralgia—Zidovudine—acquired immunodeficiency syndrome	0.000662	0.00296	CcSEcCtD
Nalidixic Acid—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.000662	0.00296	CcSEcCtD
Nalidixic Acid—Angioedema—Indinavir—acquired immunodeficiency syndrome	0.000661	0.00296	CcSEcCtD
Nalidixic Acid—Paraesthesia—Nelfinavir—acquired immunodeficiency syndrome	0.000658	0.00294	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Ritonavir—acquired immunodeficiency syndrome	0.000657	0.00294	CcSEcCtD
Nalidixic Acid—Paraesthesia—Stavudine—acquired immunodeficiency syndrome	0.000656	0.00293	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Abacavir—acquired immunodeficiency syndrome	0.000656	0.00293	CcSEcCtD
Nalidixic Acid—Erythema—Delavirdine—acquired immunodeficiency syndrome	0.000654	0.00293	CcSEcCtD
Nalidixic Acid—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.000653	0.00292	CcSEcCtD
Nalidixic Acid—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.000651	0.00291	CcSEcCtD
Nalidixic Acid—SLC22A6—brain—acquired immunodeficiency syndrome	0.000651	0.0674	CbGeAlD
Nalidixic Acid—Vertigo—Indinavir—acquired immunodeficiency syndrome	0.00065	0.00291	CcSEcCtD
Nalidixic Acid—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.000649	0.00291	CcSEcCtD
Nalidixic Acid—Paraesthesia—Abacavir—acquired immunodeficiency syndrome	0.000646	0.00289	CcSEcCtD
Nalidixic Acid—Visual impairment—Saquinavir—acquired immunodeficiency syndrome	0.000644	0.00288	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.000635	0.00284	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Saquinavir—acquired immunodeficiency syndrome	0.000632	0.00283	CcSEcCtD
Nalidixic Acid—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000631	0.00283	CcSEcCtD
Nalidixic Acid—Angioedema—Efavirenz—acquired immunodeficiency syndrome	0.000625	0.00279	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.000622	0.00278	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.000619	0.00277	CcSEcCtD
Nalidixic Acid—Arthralgia—Indinavir—acquired immunodeficiency syndrome	0.000616	0.00276	CcSEcCtD
Nalidixic Acid—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.000614	0.00275	CcSEcCtD
Nalidixic Acid—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000604	0.0027	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Lamivudine—acquired immunodeficiency syndrome	0.000603	0.0027	CcSEcCtD
Nalidixic Acid—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000601	0.00269	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000599	0.00268	CcSEcCtD
Nalidixic Acid—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.000598	0.00268	CcSEcCtD
Nalidixic Acid—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.000598	0.00267	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.000597	0.00267	CcSEcCtD
Nalidixic Acid—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000595	0.00266	CcSEcCtD
Nalidixic Acid—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.000592	0.00265	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.00059	0.00264	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000588	0.00263	CcSEcCtD
Nalidixic Acid—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.000588	0.00263	CcSEcCtD
Nalidixic Acid—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000587	0.00263	CcSEcCtD
Nalidixic Acid—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.000585	0.00262	CcSEcCtD
Nalidixic Acid—Erythema—Saquinavir—acquired immunodeficiency syndrome	0.000582	0.0026	CcSEcCtD
Nalidixic Acid—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000582	0.0026	CcSEcCtD
Nalidixic Acid—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.000582	0.0026	CcSEcCtD
Nalidixic Acid—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000582	0.0026	CcSEcCtD
Nalidixic Acid—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000581	0.0026	CcSEcCtD
Nalidixic Acid—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00058	0.0026	CcSEcCtD
Nalidixic Acid—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000579	0.00259	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000578	0.00259	CcSEcCtD
Nalidixic Acid—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000578	0.00259	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000578	0.00259	CcSEcCtD
Nalidixic Acid—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000577	0.00258	CcSEcCtD
Nalidixic Acid—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000576	0.00258	CcSEcCtD
Nalidixic Acid—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000572	0.00256	CcSEcCtD
Nalidixic Acid—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.00057	0.00255	CcSEcCtD
Nalidixic Acid—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000569	0.00255	CcSEcCtD
Nalidixic Acid—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000564	0.00253	CcSEcCtD
Nalidixic Acid—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.000557	0.00249	CcSEcCtD
Nalidixic Acid—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.000555	0.00248	CcSEcCtD
Nalidixic Acid—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000548	0.00245	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000546	0.00244	CcSEcCtD
Nalidixic Acid—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000543	0.00243	CcSEcCtD
Nalidixic Acid—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000543	0.00243	CcSEcCtD
Nalidixic Acid—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000541	0.00242	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000538	0.00241	CcSEcCtD
Nalidixic Acid—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000535	0.00239	CcSEcCtD
Nalidixic Acid—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000535	0.00239	CcSEcCtD
Nalidixic Acid—Rash—Didanosine—acquired immunodeficiency syndrome	0.00053	0.00237	CcSEcCtD
Nalidixic Acid—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.00053	0.00237	CcSEcCtD
Nalidixic Acid—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00053	0.00237	CcSEcCtD
Nalidixic Acid—Headache—Didanosine—acquired immunodeficiency syndrome	0.000527	0.00236	CcSEcCtD
Nalidixic Acid—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000526	0.00235	CcSEcCtD
Nalidixic Acid—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000525	0.00235	CcSEcCtD
Nalidixic Acid—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000524	0.00234	CcSEcCtD
Nalidixic Acid—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000524	0.00234	CcSEcCtD
Nalidixic Acid—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000523	0.00234	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000523	0.00234	CcSEcCtD
Nalidixic Acid—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000521	0.00233	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000519	0.00232	CcSEcCtD
Nalidixic Acid—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000518	0.00232	CcSEcCtD
Nalidixic Acid—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000518	0.00232	CcSEcCtD
Nalidixic Acid—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000517	0.00231	CcSEcCtD
Nalidixic Acid—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000516	0.00231	CcSEcCtD
Nalidixic Acid—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000515	0.0023	CcSEcCtD
Nalidixic Acid—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000509	0.00228	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000508	0.00227	CcSEcCtD
Nalidixic Acid—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000507	0.00227	CcSEcCtD
Nalidixic Acid—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000504	0.00226	CcSEcCtD
Nalidixic Acid—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000504	0.00226	CcSEcCtD
Nalidixic Acid—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000502	0.00225	CcSEcCtD
Nalidixic Acid—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000501	0.00224	CcSEcCtD
Nalidixic Acid—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000501	0.00224	CcSEcCtD
Nalidixic Acid—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.0005	0.00224	CcSEcCtD
Nalidixic Acid—Nausea—Didanosine—acquired immunodeficiency syndrome	0.0005	0.00224	CcSEcCtD
Nalidixic Acid—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000499	0.00223	CcSEcCtD
Nalidixic Acid—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000497	0.00222	CcSEcCtD
Nalidixic Acid—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000496	0.00222	CcSEcCtD
Nalidixic Acid—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000496	0.00222	CcSEcCtD
Nalidixic Acid—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000492	0.0022	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000486	0.00218	CcSEcCtD
Nalidixic Acid—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000484	0.00217	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000483	0.00216	CcSEcCtD
Nalidixic Acid—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000483	0.00216	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000483	0.00216	CcSEcCtD
Nalidixic Acid—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000481	0.00215	CcSEcCtD
Nalidixic Acid—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000481	0.00215	CcSEcCtD
Nalidixic Acid—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000479	0.00214	CcSEcCtD
Nalidixic Acid—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000477	0.00213	CcSEcCtD
Nalidixic Acid—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000477	0.00213	CcSEcCtD
Nalidixic Acid—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000476	0.00213	CcSEcCtD
Nalidixic Acid—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000475	0.00212	CcSEcCtD
Nalidixic Acid—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000474	0.00212	CcSEcCtD
Nalidixic Acid—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000473	0.00212	CcSEcCtD
Nalidixic Acid—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000469	0.0021	CcSEcCtD
Nalidixic Acid—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000467	0.00209	CcSEcCtD
Nalidixic Acid—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000466	0.00208	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000465	0.00208	CcSEcCtD
Nalidixic Acid—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000464	0.00208	CcSEcCtD
Nalidixic Acid—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000462	0.00207	CcSEcCtD
Nalidixic Acid—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000462	0.00207	CcSEcCtD
Nalidixic Acid—Rash—Stavudine—acquired immunodeficiency syndrome	0.000461	0.00206	CcSEcCtD
Nalidixic Acid—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00046	0.00206	CcSEcCtD
Nalidixic Acid—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000459	0.00205	CcSEcCtD
Nalidixic Acid—Headache—Stavudine—acquired immunodeficiency syndrome	0.000458	0.00205	CcSEcCtD
Nalidixic Acid—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000458	0.00205	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000456	0.00204	CcSEcCtD
Nalidixic Acid—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000456	0.00204	CcSEcCtD
Nalidixic Acid—Rash—Abacavir—acquired immunodeficiency syndrome	0.000454	0.00203	CcSEcCtD
Nalidixic Acid—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000453	0.00203	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000453	0.00203	CcSEcCtD
Nalidixic Acid—Headache—Abacavir—acquired immunodeficiency syndrome	0.000451	0.00202	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00045	0.00201	CcSEcCtD
Nalidixic Acid—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000449	0.00201	CcSEcCtD
Nalidixic Acid—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000449	0.00201	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000444	0.00199	CcSEcCtD
Nalidixic Acid—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000443	0.00198	CcSEcCtD
Nalidixic Acid—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000443	0.00198	CcSEcCtD
Nalidixic Acid—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000441	0.00197	CcSEcCtD
Nalidixic Acid—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000439	0.00196	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000436	0.00195	CcSEcCtD
Nalidixic Acid—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000435	0.00195	CcSEcCtD
Nalidixic Acid—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000434	0.00194	CcSEcCtD
Nalidixic Acid—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000434	0.00194	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000433	0.00194	CcSEcCtD
Nalidixic Acid—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000427	0.00191	CcSEcCtD
Nalidixic Acid—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000427	0.00191	CcSEcCtD
Nalidixic Acid—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000424	0.0019	CcSEcCtD
Nalidixic Acid—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000424	0.0019	CcSEcCtD
Nalidixic Acid—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000422	0.00189	CcSEcCtD
Nalidixic Acid—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000422	0.00189	CcSEcCtD
Nalidixic Acid—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00042	0.00188	CcSEcCtD
Nalidixic Acid—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000418	0.00187	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000413	0.00185	CcSEcCtD
Nalidixic Acid—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000407	0.00182	CcSEcCtD
Nalidixic Acid—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000404	0.00181	CcSEcCtD
Nalidixic Acid—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000404	0.00181	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000404	0.00181	CcSEcCtD
Nalidixic Acid—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000403	0.0018	CcSEcCtD
Nalidixic Acid—Rash—Zidovudine—acquired immunodeficiency syndrome	0.0004	0.00179	CcSEcCtD
Nalidixic Acid—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.0004	0.00179	CcSEcCtD
Nalidixic Acid—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.0004	0.00179	CcSEcCtD
Nalidixic Acid—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000398	0.00178	CcSEcCtD
Nalidixic Acid—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000395	0.00177	CcSEcCtD
Nalidixic Acid—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000392	0.00175	CcSEcCtD
Nalidixic Acid—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00039	0.00175	CcSEcCtD
Nalidixic Acid—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.00039	0.00175	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000388	0.00174	CcSEcCtD
Nalidixic Acid—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000383	0.00171	CcSEcCtD
Nalidixic Acid—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000382	0.00171	CcSEcCtD
Nalidixic Acid—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000378	0.00169	CcSEcCtD
Nalidixic Acid—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000377	0.00169	CcSEcCtD
Nalidixic Acid—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000377	0.00169	CcSEcCtD
Nalidixic Acid—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000376	0.00168	CcSEcCtD
Nalidixic Acid—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000375	0.00168	CcSEcCtD
Nalidixic Acid—Rash—Indinavir—acquired immunodeficiency syndrome	0.000372	0.00167	CcSEcCtD
Nalidixic Acid—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000372	0.00166	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000371	0.00166	CcSEcCtD
Nalidixic Acid—Headache—Indinavir—acquired immunodeficiency syndrome	0.00037	0.00166	CcSEcCtD
Nalidixic Acid—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000369	0.00165	CcSEcCtD
Nalidixic Acid—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000365	0.00163	CcSEcCtD
Nalidixic Acid—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.00036	0.00161	CcSEcCtD
Nalidixic Acid—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000358	0.0016	CcSEcCtD
Nalidixic Acid—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000355	0.00159	CcSEcCtD
Nalidixic Acid—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000354	0.00158	CcSEcCtD
Nalidixic Acid—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000353	0.00158	CcSEcCtD
Nalidixic Acid—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000352	0.00157	CcSEcCtD
Nalidixic Acid—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000351	0.00157	CcSEcCtD
Nalidixic Acid—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000351	0.00157	CcSEcCtD
Nalidixic Acid—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000349	0.00156	CcSEcCtD
Nalidixic Acid—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000349	0.00156	CcSEcCtD
Nalidixic Acid—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000341	0.00153	CcSEcCtD
Nalidixic Acid—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000339	0.00152	CcSEcCtD
Nalidixic Acid—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000338	0.00151	CcSEcCtD
Nalidixic Acid—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000337	0.00151	CcSEcCtD
Nalidixic Acid—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000336	0.0015	CcSEcCtD
Nalidixic Acid—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000336	0.0015	CcSEcCtD
Nalidixic Acid—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000334	0.0015	CcSEcCtD
Nalidixic Acid—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000331	0.00148	CcSEcCtD
Nalidixic Acid—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000326	0.00146	CcSEcCtD
Nalidixic Acid—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000325	0.00145	CcSEcCtD
Nalidixic Acid—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000325	0.00145	CcSEcCtD
Nalidixic Acid—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000321	0.00143	CcSEcCtD
Nalidixic Acid—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000317	0.00142	CcSEcCtD
Nalidixic Acid—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000314	0.00141	CcSEcCtD
Nalidixic Acid—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000314	0.0014	CcSEcCtD
Nalidixic Acid—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000311	0.00139	CcSEcCtD
Nalidixic Acid—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000311	0.00139	CcSEcCtD
Nalidixic Acid—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00031	0.00139	CcSEcCtD
Nalidixic Acid—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000309	0.00138	CcSEcCtD
Nalidixic Acid—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000302	0.00135	CcSEcCtD
Nalidixic Acid—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.0003	0.00134	CcSEcCtD
Nalidixic Acid—Rash—Saquinavir—acquired immunodeficiency syndrome	0.0003	0.00134	CcSEcCtD
Nalidixic Acid—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000299	0.00134	CcSEcCtD
Nalidixic Acid—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000298	0.00133	CcSEcCtD
Nalidixic Acid—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000293	0.00131	CcSEcCtD
Nalidixic Acid—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000288	0.00129	CcSEcCtD
Nalidixic Acid—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000286	0.00128	CcSEcCtD
Nalidixic Acid—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000285	0.00128	CcSEcCtD
Nalidixic Acid—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000284	0.00127	CcSEcCtD
Nalidixic Acid—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000282	0.00126	CcSEcCtD
Nalidixic Acid—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000269	0.0012	CcSEcCtD
